Literature DB >> 18272507

Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE study.

Martin Coenen1, Klaus Malinowski, Wilhelm Spitzer, Andreas Schuchert, Dietmar Schmitz, Michael Anelli-Monti, Sebastian K G Maier, Werner Estlinbaum, Alexander Bauer, Holger Muehling, Franz Kalscheur, Klaus Puerner, Jan Boergel, Stefan Osswald.   

Abstract

AIMS: We compared pacing rate adaptation based on closed loop stimulation (CLS) or accelerometer sensor (AS) during acute mental and physical stress in the same patient. METHODS AND
RESULTS: One month after Protos (Biotronik, Germany) pacemaker implantation, 131 chronotropically incompetent patients were randomized to AS or CLS for 3 months with crossover. Arithmetic and 6 min walk tests were performed in the non-rate-adaptive mode and AS and CLS rate-adaptive modes, respectively. At the end, patients had to select the individually preferred pacemaker sensor. Heart rate during mental stress was higher (3.0 +/- 9.2 bpm) in the CLS than in the AS mode (P = 0.004). Benefit in the walking distance compared with non-rate-adaptive pacing was similar for the two modes: added 27 +/- 96 m (AS, P = 0.013) and 30 +/- 116 m (CLS, P = 0.025). At the end of the walk, heart rate was higher by 4.8 +/- 21.4 bpm in AS than in CLS (P = 0.049). Twice as many patients preferred CLS over AS (P < 0.01).
CONCLUSION: The arithmetic test was associated with a significantly higher heart rate for CLS than for AS, showing a greater sensitivity of CLS-based rate adaptation to mental stress. Performance during physical stress was comparable. Patients preferred CLS.

Entities:  

Mesh:

Year:  2008        PMID: 18272507     DOI: 10.1093/europace/eun024

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy.

Authors:  Yeon Sik Choi; Hyoyoung Jeong; Rose T Yin; Raudel Avila; Anna Pfenniger; Jaeyoung Yoo; Jong Yoon Lee; Andreas Tzavelis; Young Joong Lee; Sheena W Chen; Helen S Knight; Seungyeob Kim; Hak-Young Ahn; Grace Wickerson; Abraham Vázquez-Guardado; Elizabeth Higbee-Dempsey; Bender A Russo; Michael A Napolitano; Timothy J Holleran; Leen Abdul Razzak; Alana N Miniovich; Geumbee Lee; Beth Geist; Brandon Kim; Shuling Han; Jaclyn A Brennan; Kedar Aras; Sung Soo Kwak; Joohee Kim; Emily Alexandria Waters; Xiangxing Yang; Amy Burrell; Keum San Chun; Claire Liu; Changsheng Wu; Alina Y Rwei; Alisha N Spann; Anthony Banks; David Johnson; Zheng Jenny Zhang; Chad R Haney; Sung Hun Jin; Alan Varteres Sahakian; Yonggang Huang; Gregory D Trachiotis; Bradley P Knight; Rishi K Arora; Igor R Efimov; John A Rogers
Journal:  Science       Date:  2022-05-26       Impact factor: 63.714

Review 2.  Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients.

Authors:  Liza Grosman-Rimon; Evan Wright; Solomon Sabovich; Jordan Rimon; Sagi Gleitman; Doron Sudarsky; Alla Lubovich; Itzhak Gabizon; Spencer D Lalonde; Sharon Tsuk; Michael A McDonald; Vivek Rao; David Gutterman; Ulrich P Jorde; Shemy Carasso; Erez Kachel
Journal:  Heart Fail Rev       Date:  2022-03-24       Impact factor: 4.214

3.  Effect of rate-adaptive pacing on performance and physiological parameters during activities of daily living in the elderly: results from the CLEAR (Cylos Responds with Physiologic Rate Changes during Daily Activities) study.

Authors:  Freddy M Abi-Samra; Narendra Singh; Benjamin L Rosin; Jerome V Dwyer; Crystal D Miller
Journal:  Europace       Date:  2013-02-17       Impact factor: 5.214

4.  Impact of closed loop stimulation on prognostic cardiopulmonary variables in patients with chronic heart failure and severe chronotropic incompetence: a pilot, randomized, crossover study.

Authors:  Joachim Proff; Béla Merkely; Roland Papp; Corinna Lenz; Peter Nordbeck; Christian Butter; Juergen Meyerhoefer; Michael Doering; Dean J MacCarter; Katharina Ingel; Thomas Thouet; Ulf Landmesser; Mattias J Roser
Journal:  Europace       Date:  2021-11-08       Impact factor: 5.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.